Crossmark

A Swedish Nationwide prospective study of oncological and reproductive outcome following fertility-sparing surgery for treatment of early stage epithelial ovarian cancer in young women

Crossref DOI link: https://doi.org/10.1186/s12885-020-07511-y

Published Online: 2020-10-19

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Johansen, Gry

Dahm-Kähler, Pernilla

Staf, Christian

Flöter Rådestad, Angelique

Rodriguez-Wallberg, Kenny A. http://orcid.org/0000-0003-4378-6181
Funding

Funding for this research was provided by:

Cancerfonden (2018-2020)

Radiumhemmets Forskningsfonder (2016-2020)

Stockholms Läns Landsting (Högre kliniska forskare)

Karolinska Institutet (Research funds)
License Information

Text and Data Mining valid from 2020-10-19

Version of Record valid from 2020-10-19
More Information

Article History

Received: 20 March 2020

Accepted: 7 October 2020

First Online: 19 October 2020

Ethics approval and consent to participate

: The Regional Ethics Committee of Stockholm approved the study (Dnr 2016/1161–31/2) for analysis of data mandatorily collected in the Swedish healthcare registries. No individuals were contacted. Informed consent was not obtained, as it is not applicable when registration data are analyzed.

: Not applicable.

: The authors have no competing interests to disclose.

Document is current

Any future updates will be listed below